Facebook Twitter Youtube Vk Rss
Facebook Twitter Youtube Vk Rss
  Trending
Sky High- 24/7 Market News Snapshot 7 Dec 2023 December 7, 2023
Siyata Mobile (NASDAQ: SYTA) Low Float First Responder Specialist Books First Post FF Follow-On Orders, Valued at $900K December 7, 2023
Patent Issuance Pushing AI-Powered Autonomous Vehicle Technologies Listing December 7, 2023
Micro Surprise- 24/7 Market News Daily Wrap 6 Dec 2023 December 6, 2023
Muy Verde- 24/7 Market News Lunch Break 6 Dec 2023 December 6, 2023
Next
Prev

Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer

  • Jun 21, 2022 at 6:41 AM
  • Anti-CD39 monoclonal antibody IPH5201 advances to Phase 2 study in lung cancer
  • Innate to receive $5M milestone payment from AstraZeneca

https://finance.yahoo.com/news/innate-pharma-announces-iph5201-phase-050000097.html

RelatedNews

Page 1 of 2
12

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent News

Follow Us

Facebook-f Twitter Youtube

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

Search by keyword

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.